SIAS
CLVS

Shine Investment Advisory Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Shine Investment Advisory Services’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$0 Hold
30
– – ﹤0.01% 780
2020
Q2 		$0 Hold
30
– – ﹤0.01% 780
2020
Q1 		$0 Buy
+30
New +$241 ﹤0.01% 792

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shine Investment Advisory Services's CLVS Position: Q3 2020 in Review

Shine Investment Advisory Services held its Clovis Oncology, Inc. (CLVS) position steady in Q3 2020 at 30 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #780.

Shine Investment Advisory Services first reported a position in CLVS in Q1 2020 and has held it in 3 quarters since. 169 funds tracked by Wall St. Rank hold CLVS as of Q3 2020.

  • Shine Investment Advisory Services held 30 shares of Clovis Oncology, Inc. worth $0 as of Q3 2020.
  • Shine Investment Advisory Services left its Clovis Oncology, Inc. share count unchanged in Q3 2020.
  • Clovis Oncology, Inc. made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #780 holding.
  • Shine Investment Advisory Services first reported a position in Clovis Oncology, Inc. in Q1 2020 and has held it in 3 quarters since.
  • 169 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.